Autosomal Dominant MPAN : Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Movement Disorders Année : 2023

Autosomal Dominant MPAN : Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes

Chloé Angelini
  • Fonction : Auteur
Christelle Marie Durand
  • Fonction : Auteur
Patricia Fergelot
  • Fonction : Auteur
Julie Deforges
  • Fonction : Auteur
Anne Vital
  • Fonction : Auteur
Patrice Menegon
  • Fonction : Auteur
Elizabeth Sarrazin
  • Fonction : Auteur
Rémi Bellance
  • Fonction : Auteur
Stéphane Mathis
  • Fonction : Auteur
Victoria Gonzalez
  • Fonction : Auteur
Mathilde Renaud
  • Fonction : Auteur
Solène Frismand
  • Fonction : Auteur
Emmanuelle Schmitt
  • Fonction : Auteur
Marie Rouanet
  • Fonction : Auteur
Brigitte Chabrol
  • Fonction : Auteur
Béatrice Desnous
Benoît Arveiler
  • Fonction : Auteur
Giovanni Stevanin
  • Fonction : Auteur
Isabelle Coupry
Cyril Goizet
  • Fonction : Auteur

Résumé

Abstract Background Mitochondrial membrane protein‐associated neurodegeneration (MPAN) is caused by mutations in the C19orf12 gene. MPAN typically appears in the first two decades of life and presents with progressive dystonia‐parkinsonism, lower motor neuron signs, optic atrophy, and abnormal iron deposits predominantly in the basal ganglia. MPAN, initially considered as a strictly autosomal recessive disease (AR), turned out to be also dominantly inherited (AD). Objectives Our aim was to better characterize the clinical, molecular, and functional spectra associated with such dominant pathogenic heterozygous C19orf12 variants. Methods We collected clinical, imaging, and molecular information of eight individuals from four AD‐MPAN families and obtained brain neuropathology results for one. Functional studies, focused on energy and iron metabolism, were conducted on fibroblasts from AD‐MPAN patients, AR‐MPAN patients, and controls. Results We identified four heterozygous C19orf12 variants in eight AD‐MPAN patients. Two of them carrying the familial variant in mosaic displayed an atypical late‐onset phenotype. Fibroblasts from AD‐MPAN showed more severe alterations of iron storage metabolism and autophagy compared to AR‐MPAN cells. Conclusion Our data add strong evidence of the realness of AD‐MPAN with identification of novel monoallelic C19orf12 variants, including at the mosaic state. This has implications in diagnosis procedures. We also expand the phenotypic spectrum of MPAN to late onset atypical presentations. Finally, we demonstrate for the first time more drastic abnormalities of iron metabolism and autophagy in AD‐MPAN than in AR‐MPAN. © 2023 The Authors. Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Fichier principal
Vignette du fichier
Autosomal Dominant MPAN Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes.pdf (16.32 Mo) Télécharger le fichier
Origine Publication financée par une institution
Licence

Dates et versions

hal-04397348 , version 1 (16-01-2024)

Licence

Identifiants

Citer

Chloé Angelini, Christelle Marie Durand, Patricia Fergelot, Julie Deforges, Anne Vital, et al.. Autosomal Dominant MPAN : Mosaicism Expands the Clinical Spectrum to Atypical Late‐Onset Phenotypes. Movement Disorders, 2023, 38 (11), pp.2103-2115. ⟨10.1002/mds.29576⟩. ⟨hal-04397348⟩
7 Consultations
4 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More